8-OH-DPAT is used as a potent and selective 5-HT1A receptor agonist in research to study serotonin receptor function; it normalizes hypolocomotion, increases wakefulness, and reduces REM sleep duration in orexin knockout mice without affecting non-REM sleep; it is also employed to investigate the role of 5-HT1A and 5-HT7 receptors in sleep-wake regulation and locomotor activity.